Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar

NCT00476476 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators